Search
Xenon Pharmaceuticals Inc
XENEAdd to Watchlist
60.960USD
+0.660+1.09%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
4.88BMarket Cap
LossP/E TTM
Xenon Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
7.50M
--
EPS(YoY)
-4.36
-45.09%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Xenon Pharmaceuticals Inc?
According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its current assets were 560.65M, with a year-on-year change of -11.75.
What are the total assets of Xenon Pharmaceuticals Inc?
According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its total assets of Xenon Pharmaceuticals Inc were 633.16M, with a year-on-year change of -20.67.
What are the total liabilities of Xenon Pharmaceuticals Inc?
According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Xenon Pharmaceuticals Inc were 51.40M, with a year-on-year change of 18.89.
What is the total equity of Xenon Pharmaceuticals Inc?
According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its total equity of Xenon Pharmaceuticals Inc was 581.76M, with a year-on-year change of -22.94.
What is the net investment of Xenon Pharmaceuticals Inc?
According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its net investment of Xenon Pharmaceuticals Inc was 218.00M, with a year-on-year change of 32.12.
What is the net financing of Xenon Pharmaceuticals Inc?
According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its net financing of Xenon Pharmaceuticals Inc was 117.11M, with a year-on-year change of 865.48.
What is the Earnings Per Share (EPS) of Xenon Pharmaceuticals Inc?
According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.36, with a year-on-year change of -45.09.
What is the Return on Equity (ROE) of Xenon Pharmaceuticals Inc?
According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -51.76, with a year-on-year change of -85.85.
What is the Return on Assets (ROA) of Xenon Pharmaceuticals Inc?
According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -48.34, with a year-on-year change of -81.82.
What is the operating profit of Xenon Pharmaceuticals Inc?
According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -373.07M, with a year-on-year change of -33.57.